| Literature DB >> 36117553 |
Hager Salah1, Omar Alsamani1, May Hassan ElLithy1, Lamyaa Samir Abdelghani1.
Abstract
Background: In March 2020, the World Health Organization (WHO) declared Severe Acute Respiratory Syndrome Coronavirus 2 (SARS2-CoV-2) as global pandemic. This health crisis has overwhelmed the healthcare system, leading to unprecedented morbidity and mortality rates. During this pandemic, pharmacies tried to maintain their services either through remote services or face-to-face dispensing and consultation.Entities:
Keywords: Pharmaceutical Care; Remote Services; SARS2-CoV-2 - Face-to-Face Counseling - Patient Perceptions
Year: 2022 PMID: 36117553 PMCID: PMC9467934 DOI: 10.1016/j.jsps.2022.09.006
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.562
Figure 1Organizational strategies to address patient safety issues arising from the current COVID-19 pandemic response.
Figure 2Announced social media post to educate the patient about new dispensation process
Demographic and participants characteristics (Total participants= 641).
| Male | 339 (52.9%) |
| Female | 302 (47.1%) |
| ≤19 | 120 (18.7%) |
| 20-39 | 251 (39.2%) |
| 40- 59 | 143 (22.3%) |
| ≥60 | 127 (19.8%) |
| Single | 131 (20.4%) |
| Married | 470 (73.3%) |
| Divorced | 18 (2.8%) |
| Widower | 22 (3.4%) |
| Unlettered | 11 (1.7%) |
| Elementary | 36 (5.6%) |
| Secondary | 211 (32.9%) |
| Diploma | 82 (12.8%) |
| University | 301 (47.0%) |
| Unemployed | 131 (20.4%) |
| Employee | 307 (47.9%) |
| Retired | 159 (24.8%) |
| Student | 44 (6.9%) |
| Contact with SARS2-CoV-2 patient | 19 (3.0%) |
| Never infected or contact positive SARS2-CoV-2 patient | 543 (84.7%) |
| Recovered from SARS2-CoV-2 | 79 (12.3%) |
| Healthy | 315 (49.1%) |
| Chronic | 326 (50.9%) |
| New prescription | 373 (58.2%) |
| Refill prescription | 268 (41.8%) |
Pharmacy adaptation strategies and services during SARS2-CoV-2 pandemic satisfaction survey.
| 286 (44.6%) | 275 (42.9%) | 51(8.0%) | 14(2.2%) | 15(2.3%) | |
| 279(43.5%) | 261(40.7%) | 66(10.3%) | 24(3.7%) | 11(1.7%) | |
| 252(39.3%) | 194(30.3%) | 115(17.9%) | 44(6.9%) | 36(5.6%) | |
| 272(42.4%) | 241(37.6%) | 78(12.2%) | 32(5.0%) | 18(2.8%) | |
| 233(36.3%) | 242(37.8%) | 105(16.4%) | 40(6.2%) | 21(3.3%) | |
| 311(48.5%) | 246(38.4%) | 64(10.0%) | 13(2.0%) | 7(1.1%) | |
| 321(50.1%) | 244(38.1%) | 45(7.0%) | 20(3.1%) | 11(1.7%) | |
| 322(50.2%) | 235(36.7%) | 50(7.8%) | 23(3.6%) | 11(1.7%) | |
| 261(40.7%) | 202(31.5%) | 88(13.7%) | 51(8.0%) | 39(6.1%) | |
| 314(49.0%) | 251(39.2%) | 55(8.6%) | 14(2.2%) | 7(1.1%) | |
| 292(45.6%) | 239(37.3%) | 60(9.4%) | 25(3.9%) | 25(3.9%) | |
| 274(42.7%) | 238(37.1%) | 87(13.6%) | 24(3.7%) | 18(2.8%) | |
| 208(32.4%) | 190(29.6%) | 120(18.7%) | 72(11.2%) | 51(8.0%) |
Overall satisfaction survey:
| 323(50.4%) | 250(39.0%) | 49(7.6%) | 11(1.7%) | 8(1.2%) | |
| 227(35.4%) | 251(39.2%) | 121(18.9%) | 24(3.7%) | 18(2.8%) | |
| 253(39.5%) | 231(36.0%) | 111(17.3%) | 20(3.1%) | 26(4.1%) | |
| 252(39.5%) | 252(39.3%) | 94(14.7%) | 29(4.5%) | 13(2.0%) | |
| 274(42.7%) | 271(42.3%) | 61(9.5%) | 23(3.6%) | 12(1.9%) |
Figure 3Overall Satisfaction across various demographics.
Univariate analysis for the level of agreement for pharmacy services.
| 4.31 ± 0.82 | 4.00 ± 0.92 | 4.15 ± 0.88 | 4.20 ± 0.78 | 4.31 ± 0.78 | 4.39 ± 0.82 | |
| 4.35 ± 0.78 | 3.93 ± 1.02 | 3.89 ± 1.14 | 4.00 ± 1.01 | 4.13 ± 0.90 | 4.06 ± 1.03 | |
| 4.39 ± 0.85 | 4.05 ± 1.00 | 4.18 ± 0.85 | 4.02 ± 1.04 | 4.14 ± 0.99 | 4.00 ± 1.23 | |
| 4.36 ± 0.72 | 4.08 ± 0.86 | 4.02 ± 1.04 | 4.25 ± 0.79 | 4.29 ± 0.82 | 4.33 ± 0.78 | |
| p= 0.58 | p= 0.58 | p= 0.16 | p= 0.13 | p= 0.20 | p= 0.009* | |
| 4.32 ± 0.83 | 4.03 ± 0.94 | 4.03 ± 1.08 | 4.12 ± 0.92 | 4.20 ± 0.88 | 4.18 ± 0.98 | |
| 4.38 ± 0.75 | 3.97 ± 1.00 | 4.04 ± 1.08 | 4.06 ± 0.97 | 4.20 ± 0.89 | 4.14 ± 1.05 | |
| p= 0.52 | p= 0.51 | p= 0.40 | p= 0.60 | p= 0.97 | p= 0.96 | |
| 4.00 ± 0.77 | 3.90 ± 0.94 | 4.18 ± 0.60 | 4.36 ± 0.50 | 4.18 ± 0.60 | 4.45 ± 0.52 | |
| 4.33 ± 1.04 | 4.25 ± 1.02 | 4.33 ± 1.04 | 4.25 ± 1.02 | 4.16 ± 1.18 | 4.30 ± 1.09 | |
| 4.45 ± 0.67 | 4.12 ± 0.89 | 4.16 ± 0.95 | 4.18 ± 0.89 | 4.27 ± 0.88 | 4.18 ± 0.98 | |
| 4.30 ± 0.73 | 4.00 ± 0.87 | 3.98 ± 0.96 | 4.07 ± 0.91 | 4.21 ± 0.80 | 4.26 ± 0.96 | |
| 4.31 ± 0.85 | 3.89 ± 1.03 | 3.92 ± 1.09 | 4.01 ± 0.98 | 4.15 ± 0.88 | 4.09 ± 1.04 | |
| p= 0.14 | p= 0.038* | p= 0.018* | p= 0.15 | p= 0.40 | p= 0.37 | |
| 4.44 ± 0.69 | 4.19 ± 0.86 | 4.25 ± 0.87 | 4.28 ± 0.86 | 4.37 ± 0.77 | 4.38 ± 0.80 | |
| 4.37 ± 0.80 | 3.99 ± 1.00 | 4.00 ± 1.09 | 4.00 ± 1.01 | 4.14 ± 0.95 | 4.04 ± 1.10 | |
| 4.27 ± 0.85 | 3.89 ± 0.98 | 3.95 ± 1.03 | 4.15 ± 0.84 | 4.20 ± 0.82 | 4.25 ± 0.92 | |
| 4.25 ± 0.83 | 3.95 ± 0.93 | 3.88 ± 0.84 | 3.97 ± 0.95 | 4.11 ± 0.92 | 4.00 ± 1.12 | |
| p= 0.25 | p= 0.06* | p= 0.02* | p= 0.03* | p= 0.10* | p= 0.019* | |
| 4.21 ± 0.97 | 3.73 ± 0.99 | 3.89 ± 1.10 | 4.15 ± 0.76 | 4.36 ± 0.59 | 3.98 ± 1.24 | |
| 4.36 ± 0.78 | 4.00 ± 0.98 | 4.02 ± 1.05 | 4.10 ± 0.95 | 4.21 ± 0.89 | 4.18 ± 1.01 | |
| 4.31 ± 0.84 | 4.11 ± 0.89 | 4.17 ± 0.79 | 4.02 ± 0.93 | 4.07 ± 0.88 | 4.13 ± 0.97 | |
| p= 0.79 | p= 0.26 | p= 0.64 | p= 0.64 | p= 0.20 | p= 0.52 | |
| 4.38 ± 0.79 | 4.03 ± 0.99 | 4.04 ± 1.06 | 4.05 ± 0.98 | 4.15 ± 0.93 | 4.12 ± 1.08 | |
| 4.32 ± 0.79 | 3.96 ± 0.97 | 4.03 ± 0.99 | 4.14 ± 0.90 | 4.27 ± 0.83 | 4.23 ± 0.91 | |
| p= 0.39 | p= 0.52 | p= 0.84 | p= 0.67 | p= 0.23 | p= 0.57 | |
| 4.31 ± 0.84 | 3.96 ± 1.00 | 3.97 ± 1.06 | 4.03 ± 1.00 | 4.16 ± 0.91 | 4.11 ± 1.05 | |
| 4.41 ± 0.71 | 4.06 ± 0.92 | 4.13 ± 0.96 | 4.18 ± 0.85 | 4.25 ± 0.85 | 4.23 ± 0.95 | |
| p= 0.32 | p= 0.23 | p= 0.06* | p= 0.14 | p= 0.24 | p= 0.22 | |